This comprehensive one-day continuing medical education program in neuromodulation features an outstanding faculty from the Departments of Neurosurgery, Neurology, and Anesthesia at the David Geffen School of Medicine at UCLA. The purpose of the course is to provide an update on the latest multidisciplinary management and application of medical devices for an array of neurologic diagnoses, including movement disorders, epilepsy, chronic pain, and head and facial pain. There will be specific emphasis on new and emerging treatment options, including deep brain stimulation (DBS), responsive neurostimulation, emerging neurotechnologies, and therapies on the horizon. Alternative treatments, including first-line medical management, botulinum toxin therapy, and adjunctive therapies will also be discussed. The course will focus on personalizing therapy, both with respect to patient selection and targeting therapy. To integrate and ensure audience participation, patient testimonials will take place throughout the day. Attendees are encouraged to bring in their own cases for discussion.

Target Audience

Neurosurgeons (functional and general), neurologists (general, movement disorder, and epilepsy), psychiatrists, psychologists, pain management physicians, primary care physicians, allied-health professionals, and neurosurgery, neurology, and psychiatry residents and fellows